← Open Payments lookup

SARAH NOBLE: Open Payments

NPI 1366646101 · PHILADELPHIA, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,038 in 47 payments from 11 companies in 2025. Trend: 2023 $1,501 · 2024 $285 · 2025 $1,038

Food & beverage: $1,038
CompanyPaymentsAmount
Vanda Pharmaceuticals Inc.9$208
Janssen Pharmaceuticals, Inc6$151
Teva Pharmaceuticals USA, Inc.6$143
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)7$138
Otsuka America Pharmaceutical, Inc.7$136
ABBVIE INC.4$77
Alkermes, Inc.2$52
E.R. Squibb & Sons, L.L.C.2$52
Neurocrine BioSciences, Inc.2$38
Takeda Pharmaceuticals U.S.A., Inc.1$21

Products named: FANAPT, INVEGA SUSTENNA, CAPLYTA, AUSTEDO XR, REXULTI, VRAYLAR, ABILIFY ASIMTUFII, ARISTADA.

Industry payments across PA — which companies pay providers there.